Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

The purpose of this study is to conduct clinical research on [68Ga] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.

Inclusion Criteria:

• 1: 18-85 years old

  2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis

  3: Ability to understand and sign informed consent forms

  4: Expected survival period exceeding 6 months and able to receive follow-up

  5: Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc

Exclusion Criteria:

• 1: Pregnant or lactating women

  2: Patients allergic to research drug ingredients

  3: Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 μ mol/L)

  4: Patients who participate in other clinical trials and interfere with the results of this study

  5: Patients with severe illness who cannot cooperate with the examination